Academic Medical Journal

«Family Medicine»

International bilingual academic journal
ISSN 2307-5112 (Print)
ISSN 2412-8708 (Online)

Current Issue

No. 1 (2021)

When submitting a manuscript to the journal, authors must confirm its compliance with all the requirements set by the editors. In case of non-compliance of the submitted work with the clauses of these requirements, the editorial board will return the materials to the authors for revision. (Read more)

The editorial board of "Family medicine" accepts articles for consideration, provided that this is the first publication, the article has not been transferred for publication to other publications and the design is made in accordance with the requirements of scientific articles of our journal. (Read more)

All scientific articles submitted to the journal are subject to mandatory peer review. The work of the journal is based on the principles of independent and objective review - double-blind. (Read more)

All manuscripts, submitted for publication, will be analyzed for their originality, methodology, importance, quality, ethical nature and compliance with the goals and objectives of the journal. The editor-in-chief has the right to evaluate the editorial and scientific content of the journal and determines the timing of each material publication. (Read more)

“Family medicine” Journal is governed by the rules recommended by the International Committee of Medical Journal Editors (ICMJE) (Uniform Requirements for Manuscripts Submitted to Biomedical Journals). Works using human material must comply with the 2013 Helsinki Declaration. (Read more)


Frequency of journal is quarterly
The journal was founded in 1999

The journal  «Family medicine» was founded in 1999 to inform medical society about achievements, problems and prospects of family medicine development in Ukraine. From the beginning the journal promotes family medicine, describes the activities of Ukraine Association of Family Medicine, publishes the reviews of the global formation and evidence of advantages of the primary medical care organization based on principals of family medicine in different countries.  Due to the constant participation of the Shupyk National Healthcare University of Ukraine in journal development and significant personal efforts of the first chief editor of the journal – prominent Ukrainian scientist and teacher prof. Grygorii Lysenko, - «Family Medicine» publishes wide spectrum of the original researches and recommendations in different fields from the leaders of medical science of Ukraine. In short time  the journal become the leading edition, not only for family physicians but also for a wide circle of other medical specialists in Ukraine.

Editorial Team

Current Issue

No. 1 (2021)
View All Issues

Popular Articles

No. 1 (2021)

Plasma Hemostasis in Patients with Essential Hypertension and Non-alcoholic Fatty Liver Disease Under Conditions of Hypercholesterolemia and Concomitant Statin Therapy


In the modern scientific world, it has been proven that non-alcoholic fatty liver disease (NAFLD) is a marker of the risk of cardiovascular (CV) events, and therefore, attention and control of risk factors for CV diseases is important. Considering the prevalence of atherogenic dyslipidemias and their proven effect on the development of thrombotic CV complications in patients with NAFLD, it is...

No. 1 (2021)

Dexibuprofen in the Practice of a Family Doctor


Pain is an unpleasant sensory and emotional sensation associated with tissue damage or described in terms of such damage. Pain of different localization is one of the most common symptoms in modern clinical practice and one of the most common reasons for seeking medical care at the outpatient stage. One of the most promising and effective pathogenetic means of protection of peripheral pain...

No. 5-6 (2020)

USA Got the Rights to the Drug Arlevert®


Міжнародна компанія Castle Creek Pharmaceuticals (США), яка спеціалізується на розробці інноваційних засобів для лікування пацієнтів із патологією голови та шиї, дерматологічними захворюваннями, а також іншими клінічними станами, отримала від компанії Hennig Arzneimittel GmbH & Co. KG (Німеччина) ексклюзивні права на використання препарату Арлеверт® у Сполучених Штатах Америки.

Stay tuned! Subscribe now

Subscribe, so you never miss important information about achievements of medicine! We offer an annual subscription to our Journal